Shilpa Medicare Limited appoints Dr. Vellaian Karuppiah as Chief Operating Officer - Formulations
Published on: April 26, 2026, 9:38 p.m. | Source: scanx.trade
Shilpa Medicare Limited has appointed Dr. Vellaian Karuppiah as Chief Operating Officer (COO) - Formulations effective 23 April 2026, approved by the Nomination and Remuneration Committee. With over 33 years of pharmaceutical experience across organizations like Gland Pharma, Dr. Reddy's Laboratories, and Actavis, Dr. Karuppiah brings expertise in R&D, regulatory affairs, manufacturing, and supply chain management. The appointment aims to strengthen formulation business operations, enhance operational efficiencies, and support long-term sustainable growth.
